Today on the show Technori’s Scott Kitun and Partner with Kelley Drye & Warren LLP Matt Luzadder talk to John Climaco from CNS Pharma, a company working towards developing a drug to battle brain cancer. Scott and Matt also talk to Daniel Downs from R3 Printing, a company revolutionizing 3D printing.
To invest in CNS Pharma click here and to invest in R3 Printing click here.
Make sure to follow Technori on Facebook and Twitter.